Tuberculosis

CDC: Updated Recommendations for Latent TB Infection Treatment

CDC: Updated Recommendations for Latent TB Infection Treatment

By

The CDC has issued updated recommendations regarding the use of 3HP for the treatment of latent tuberculosis.

Could a New Universal Tuberculosis Regimen Help End the TB Pandemic?

Could a New Universal Tuberculosis Regimen Help End the TB Pandemic?

By

The Lancet Respiratory Medicine staged a debate between proponents and opponents of pan-TB regimens to tackle the current suboptimal worldwide management of TB resistance.

Simple Blood-Based PCR Test Can Predict Progression to Tuberculosis

Simple Blood-Based PCR Test Can Predict Progression to Tuberculosis

By

Study identifies and validates a simple PCR-based test from accessible blood samples that predicts TB in heterogeneous African populations with intermediate to high TB burdens.

Infections Complicating the Use of Monoclonal Antibodies for Malignancy

Infections Complicating the Use of Monoclonal Antibodies for Malignancy

By

In this review, David C. Helfgott, MD, editorial advisory board member for Infectious Disease Advisor, focuses on infectious complications from the use of monoclonal antibodies for malignancy.

Cavity Volume and Proximity to Airway May Affect Tuberculosis Treatment

Cavity Volume and Proximity to Airway May Affect Tuberculosis Treatment

By

Large cavitary lung disease may increase cough frequency that lasts for a longer duration in individuals with tuberculosis.

CDC: Declining Incidence of TB in the United States Remains Inadequate for Elimination

CDC: Declining Incidence of TB in the United States Remains Inadequate for Elimination

By

Control of active tuberculosis (TB) and a major effort to decrease latent TB infection are both necessary to reduce morbidity and achieve TB elimination in the United States.

Effectiveness of Daily vs Thrice-Weekly Tuberculosis Regimens in HIV Patients

Effectiveness of Daily vs Thrice-Weekly Tuberculosis Regimens in HIV Patients

By

HIV-positive patients with pulmonary tuberculosis benefited from daily antituberculosis therapy in terms of effectiveness and rifampicin resistance.

Adverse Pregnancy Outcomes With Isoniazid Preventive Therapy in HIV

Adverse Pregnancy Outcomes With Isoniazid Preventive Therapy in HIV

By

Findings from this phase 4 study call for a re-evaluation of the current WHO and CDC guidelines of isoniazid preventive therapy for the prevention of tuberculosis in pregnant women with HIV.

Shorter Tuberculosis Regimens Associated With Greater Treatment Adherence

Shorter Tuberculosis Regimens Associated With Greater Treatment Adherence

By

Children receiving 3 months of once-weekly isoniazid and rifapentine were more likely to complete therapy than those receiving 9 months of daily isoniazid.

Mortality in HIV-Infected Children Predicted by Urine TB Lipoarabinomannan

Mortality in HIV-Infected Children Predicted by Urine TB Lipoarabinomannan

By

Benefits of urine lipoarabinomannan include its rapid point-of-care platform, low cost, and readily accessible sample type.

Decreased Tuberculosis Risk With Metformin vs Sulfonylureas

Decreased Tuberculosis Risk With Metformin vs Sulfonylureas

By

Patients with type 2 diabetes treated with sulfonylureas may be at a higher risk of contracting tuberculosis.

Survival Outcomes Improved With Concurrent Treatment for Multidrug-Resistant TB and HIV

Survival Outcomes Improved With Concurrent Treatment for Multidrug-Resistant TB and HIV

By

Co-infected participants treated concurrently for multidrug-resistant tuberculosis and HIV had similar survival to participants with multidrug-resistant tuberculosis alone.

Shorter pediatric tuberculosis treatment linked to higher completion rates

Children with tuberculosis who received 3 months of directly observed preventative therapy were >25 times more likely to complete their treatment regimen than those who received 9 months of self-administered therapy.

Update to Pulmonary Tuberculosis Screening Recommendations

Update to Pulmonary Tuberculosis Screening Recommendations

By

Report updated the 2006 American College of Chest Physicians clinical practice guideline for cough due to TB and other chronic infections.

Update on Latent Tuberculosis Testing and Treatment

Update on Latent Tuberculosis Testing and Treatment

By

A representative from the California Department of Public Health discusses latent TB infection testing and treatment recommendations and reasons why US physicians have been slow to test for and treat for the condition.

Likelihood of Self-Administered Treatment Completion for Latent TB

Likelihood of Self-Administered Treatment Completion for Latent TB

By

The iAdhere study found that once-weekly self-administration of isoniazid and rifapentine had high treatment completion rates in the United States, Hong Kong, Spain, and South Africa.

Automated Molecular Assay Detects Drug-Resistant Tuberculosis

Automated Molecular Assay Detects Drug-Resistant Tuberculosis

An automated molecular assay can detect Mycobacterium tuberculosis with resistance to drugs directly from sputum specimens.

Drug-Resistant Tuberculosis to Increase in 4 High-Burden Countries

Drug-Resistant Tuberculosis to Increase in 4 High-Burden Countries

Additional strategies to prevent transmission will be necessary to stop multidrug-resistant (MDR) or extensively drug-resistant tuberculosis in countries with a high burden of MDR tuberculosis.

Challenges in Diagnosing Tuberculous Meningitis

Challenges in Diagnosing Tuberculous Meningitis

By

Diagnosis of tuberculous meningitis is challenging, although new, next-generation rapid POC testing holds promise for greatly improved sensitivity. Shorter and more effective treatments are needed.

Isoniazid-Rifapentine for Latent TB Sees High Completion Rates

Isoniazid-Rifapentine for Latent TB Sees High Completion Rates

By

Isoniazid-rifapentine regimen sees high completion rates for latent tuberculosis infection.

Latent Tuberculosis May Benefit From 3-Month Rifapentine, Isoniazid Tx

Latent Tuberculosis May Benefit From 3-Month Rifapentine, Isoniazid Tx

By

Three months of rifapentine + isoniazid using directly observed therapy resulted in a higher completion rate and no loss of follow-up for latent tuberculosis.

Metformin Reduces Mortality During Tuberculosis Therapy

Metformin Reduces Mortality During Tuberculosis Therapy

By

Researchers assess all-cause mortality during tuberculosis treatment in patients with diabetes, the use of metformin, and effect sputum culture-conversion rates.

Tuberculosis Diagnosis: Improved Blood Test by Qiagen to Hit Shelves

Tuberculosis Diagnosis: Improved Blood Test by Qiagen to Hit Shelves

By

Qiagen announced on October 5, 2017, the marketing of an improved blood test for tuberculosis infection.

Accuracy of Negative Tuberculin Skin Test in Predicting In-Hospital Tuberculosis  Mortality

Accuracy of Negative Tuberculin Skin Test in Predicting In-Hospital Tuberculosis Mortality

By

The relationship between negative tuberculin skin test and in-hospital mortality has not been previously studied.

Risk for TB Infection Predicted by New Scoring System

Risk for TB Infection Predicted by New Scoring System

By

This new risk score may guide the identification of high-risk people who would benefit from preventative measures.

Time to Sputum Culture Conversion Similar in Isoniazid-Resistant and Susceptible TB

Time to Sputum Culture Conversion Similar in Isoniazid-Resistant and Susceptible TB

By

A new study examined whether isoniazid resistance was associated with variations in treatment outcomes in patients receiving standard first-line pharmacotherapy for TB.

Tuberculosis Detection Could Improve With Conversion Value Change

Tuberculosis Detection Could Improve With Conversion Value Change

A change of QuantiFERON-TB interferon (IFN)γ values could improve tuberculosis detection.

<i>M tuberculosis</i> Disrupts Regulatory Macrophage Pathways Driving Immunopathology

M tuberculosis Disrupts Regulatory Macrophage Pathways Driving Immunopathology

By

Mycobacterium tuberculosis engages the host immune response to drive immunopathology and tissue destruction by disrupting negative regulatory pathways in human macrophages.

Update on Safe, Effective Treatments for Latent Tuberculosis Infection

Update on Safe, Effective Treatments for Latent Tuberculosis Infection

By

A recent update of a meta-analysis evaluating treatments for latent tuberculosis infection found that several regimens, including those with a low pill burden and short duration, were safe and effective.

Mortality in MDR TB Decreases With Directly Observed Therapy

Mortality in MDR TB Decreases With Directly Observed Therapy

By

A decrease in all-cause mortality associated with multidrug-resistant tuberculosis (TB) can be correlated with an increase in directly observed therapy.

Sign Up for Free e-newsletters